![]() |
|
|
Vol. 289, Issue 3, 1600-1610, June 1999
Departments of Pediatrics and Pharmacology, Children's Hospital of
Philadelphia, University of Pennsylvania, Philadelphia,
Pennsylvania (J.T., O.Z., D.C., M.B.R) and Department of Neurology,
The Johns Hopkins University, Baltimore, Maryland (J.D.R.)
Several subtypes of Na+-dependent glutamate transporters
have been pharmacologically differentiated in brain tissues. Five distinct cDNA clones that express Na+-dependent glutamate
transport activity have been isolated. One goal of the current study
was to compare the pharmacological properties of the rat GLT-1 subtype
of transporter to those identified previously using rat brain tissues.
To accomplish this goal, GLT-1 was stably transfected into two
different cell lines that express low levels of endogenous transport
activity (MCB and L-M (TK-)). Several clones stably transfected with
GLT-1 were isolated. In each cell line, Na+-dependent
glutamate transport activity was saturable with similar Km values (19 and 37 µM). The
pharmacological properties of GLT-1-mediated transport in these cell
lines paralleled those observed for the predominant pharmacology
observed in cortical crude synaptosomes. These data are consistent with
other lines of evidence that suggest that GLT-1 may be sufficient to
explain most of the Na+-dependent glutamate transport
activity in cortical synaptosomes. Although recent studies using HeLa
cells have suggested that GLT-1 can be rapidly up-regulated by
activation of protein kinase C (PKC), modulation of PKC or phosphatase
activity had no effect on GLT-1-mediated activity in these transfected
cell lines. To determine if GLT-1 regulation by PKC is cell-specific,
HeLa cells, which endogenously express the EAAC1 subtype of
transporter, were stably transfected with GLT-1. Although
EAAC1-mediated activity was increased by activation of PKC, we found no
evidence for regulation of GLT-1. Despite the present findings, GLT-1
activity may be regulated by PKC under certain conditions.
This article has been cited by other articles:
![]() |
S. Colleoni, A. A. Jensen, E. Landucci, E. Fumagalli, P. Conti, A. Pinto, M. De Amici, D. E. Pellegrini-Giampietro, C. De Micheli, T. Mennini, et al. Neuroprotective Effects of the Novel Glutamate Transporter Inhibitor (-)-3-Hydroxy-4,5,6,6a-tetrahydro-3aH-pyrrolo[3,4-d]-isoxazole-4-carboxylic Acid, Which Preferentially Inhibits Reverse Transport (Glutamate Release) Compared with Glutamate Reuptake J. Pharmacol. Exp. Ther., August 1, 2008; 326(2): 646 - 656. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Pita-Almenar, M. S. Collado, C. M. Colbert, and A. Eskin Different Mechanisms Exist for the Plasticity of Glutamate Reuptake during Early Long-Term Potentiation (LTP) and Late LTP J. Neurosci., October 11, 2006; 26(41): 10461 - 10471. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Fang, Y. Huang, and Z. Zuo Enhancement of substrate-gated Cl- currents via rat glutamate transporter EAAT4 by PMA Am J Physiol Cell Physiol, May 1, 2006; 290(5): C1334 - C1340. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Dunlop, H. B. McIlvain, T. A. Carrick, B. Jow, Q. Lu, D. Kowal, S. Lin, A. Greenfield, C. Grosanu, K. Fan, et al. Characterization of Novel Aryl-Ether, Biaryl, and Fluorene Aspartic Acid and Diaminopropionic Acid Analogs as Potent Inhibitors of the High-Affinity Glutamate Transporter EAAT2 Mol. Pharmacol., October 1, 2005; 68(4): 974 - 982. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kalandadze, Y. Wu, K. Fournier, and M. B. Robinson Identification of Motifs Involved in Endoplasmic Reticulum Retention-Forward Trafficking of the GLT-1 Subtype of Glutamate Transporter J. Neurosci., June 2, 2004; 24(22): 5183 - 5192. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Chen, V. Mahadomrongkul, U. V. Berger, M. Bassan, T. DeSilva, K. Tanaka, N. Irwin, C. Aoki, and P. A. Rosenberg The Glutamate Transporter GLT1a Is Expressed in Excitatory Axon Terminals of Mature Hippocampal Neurons J. Neurosci., February 4, 2004; 24(5): 1136 - 1148. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I. Gonzalez and M. B. Robinson Protein KINASE C-Dependent Remodeling of Glutamate Transporter Function Mol. Interv., February 1, 2004; 4(1): 48 - 58. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kalandadze, Y. Wu, and M. B. Robinson Protein Kinase C Activation Decreases Cell Surface Expression of the GLT-1 Subtype of Glutamate Transporter. REQUIREMENT OF A CARBOXYL-TERMINAL DOMAIN AND PARTIAL DEPENDENCE ON SERINE 486 J. Biol. Chem., November 22, 2002; 277(48): 45741 - 45750. [Abstract] [Full Text] [PDF] |
||||